Psoriatic Arthritis
From the Journals
Long-term efficacy, safety data for ixekizumab in pediatric psoriasis reported
No new safety findings during weeks 48 to 108 of the trial were reported, including no new cases of inflammatory bowel disease or Candida...
From the Journals
Secukinumab’s antipsoriatic effects confirmed in U.S. patient population
Results from a postmarketing trial conducted solely at U.S. centers found similar, albeit lower, responses to secukinumab 300 mg than was noted in...
Latest News
Hypocaloric diet controls joint activity in psoriatic arthritis – regardless of weight loss
A hypocaloric diet in patients with psoriatic arthritis improved disease activity and body composition.
Conference Coverage
Apremilast has neutral effect on vascular inflammation in psoriasis study
“There has been a keen interest in understanding how psoriasis therapies impact cardiovascular risk.”
From the Journals
Trial gives new guidance for choosing initial PsA treatment
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than...
Latest News
Study links air pollution to psoriasis flares
The findings underscore the need for clinicians to “consider environmental/external triggers in patients with chronic inflammatory diseases...
From the Journals
CV risk biomarkers tentatively identified in psoriatic disease
Troponin I and NT-proBNP levels were linked to cardiovascular risk independently of the Framingham Risk Score.
From the Journals
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasis
Survival rates were highest for rituximab in rheumatoid arthritis and golimumab in axial spondyloarthritis in a study of two Danish registries.
From the Journals
Methotrexate plus leflunomide proves effective for PsA
The combination therapy outperformed methotrexate monotherapy as a treatment option for patients with psoriatic arthritis (PsA), though it did...
Guidelines
Updated perioperative guidance says when to hold antirheumatics
Rheumatologists and orthopedic surgeons revise advice on JAK inhibitors and add new medications.
From the Journals
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis finds
The results highlight the need for proper assessment of body weight and cardiovascular risk factors in patients with PsA at the onset of disease...